2017 Moderna White Paper on DNA and mRNA Vaccines

https://www.modernatx.com/sites/default/files/RNA_Vaccines_White_Paper_Moderna_050317_v8_4.pdf

Good read on method of action of these vaccines and why these vaccines are more “beneficial”, ie profitable (moreso mRNA as DNA vaccines method of action has proven to be much more difficult since it needs to get into the actual cell nucleus)

Check out one of the 2 authors who worked at Mitt Romney’s Bain Capital and graduated from DerpState China-supported HARVARD

Evan Rachlin, M.D.

Senior Director of Strategic Planning

Dr. Rachlin leads Strategy across Moderna’s portfolio of mRNA medicines.Prior to joining Moderna, Dr. Rachlin was a principal at Bain Capital Ventures, an engagement manager at McKinsey & Company, and an associate in the Portfolio and Decision Analysis Group at Pfizer. He received his M.D./M.B.A. from Harvard University

We may need to dig on this guy!